While low islet PAX5 expression in ND individuals was confirmed in our cohort, expression at both mRNA and protein levels was upregulated in T2D, with immunostaining showing that the upregulation took place in β cells. This evidence concerns the gene PAX5 and type 2 diabetes mellitus.